Unveiling hierarchy and spatial distribution of O 6 ‐methylguanine‐DNA methyltransferase promoter methylation in World Health Organization grade 2–3 gliomas
Cancer Science · 2024
DOI: 10.1111/cas.16268 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Mingxiao Li und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, China-Japan Friendship Hospital, Beijing, China. Hauptthemen laut MEDLINE: DNA Methylation, DNA Modification Methylases, Tumor Suppressor Proteins, O(6)-Methylguanine-DNA Methyltransferase. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
This study investigated the role of O 6 ‐methylguanine‐DNA methyltransferase promoter (MGMTp) methylation hierarchy and heterogeneity in grade 2–3 gliomas, focusing on variations in chemotherapy benefits and resection dependency. A cohort of 668 newly diagnosed grade 2–3 gliomas, with comprehensive clinical, radiological, and molecular data, formed the basis of this analysis. The extent of resection was categorized into gross total resection (GTR ≥100%), subtotal resection (STR >90%), and partial resection (PR ≤90%). MGMTp methylation levels were examined using quantitative pyrosequencing. Our findings highlighted the critical role of GTR in improving the prognosis for astrocytomas (IDH1/2‐mutant and 1p/19q non‐codeleted), contrasting with its lesser significance for oligodendrogliomas (IDH1/2 mutation and 1p/19q codeletion). Oligodendrogliomas demonstrated the highest average MGMTp methylation levels (median: 28%), with a predominant percentage of methylated cases (average methylation levels >20%). Astrocytomas were more common in the low‐methylated group (10%–20%), while IDH wild‐type gliomas were mostly unmethylated (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, China-Japan Friendship Hospital, Beijing, China.
- Department of Neurosurgical Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
- Department of Neurosurgery, Peking University Third Hospital, Beijing, China.
ORCID-Profile: Quan Cheng, Song Lin
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, M., Liu, J., Weng, J., Dong, G., Chen, X., Cui, Y., Ren, X., Shen, S., Jiang, H., Zhang, X., Zhao, X., Li, M., Wang, X., Ren, H., Li, Q., Zhang, Y., Cheng, Q., Yu, Y., & Lin, S. (2024). Unveiling hierarchy and spatial distribution of O 6 ‐methylguanine‐DNA methyltransferase promoter methylation in World Health Organization grade 2–3 gliomas. Cancer Science. https://doi.org/10.1111/cas.16268
Vancouver
Li M, Liu J, Weng J, Dong G, Chen X, Cui Y, et al. Unveiling hierarchy and spatial distribution of O 6 ‐methylguanine‐DNA methyltransferase promoter methylation in World Health Organization grade 2–3 gliomas. Cancer Science. 2024. doi:10.1111/cas.16268
BibTeX
@article{Li2024,
author = {Li, Mingxiao and Liu, Jiang and Weng, Jiancong and Dong, Gehong and Chen, Xuzhu and Cui, Yong and Ren, Xiaohui and Shen, Shaoping and Jiang, Haihui and Zhang, Xiaokang and Zhao, Xuzhe and Li, Ming and Wang, Xijie and Ren, Hongxiang and Li, Qiang and Zhang, Yulian and Cheng, Quan and Yu, Yanbing and Lin, Song},
title = {Unveiling hierarchy and spatial distribution of O 6 ‐methylguanine‐DNA methyltransferase promoter methylation in World Health Organization grade 2–3 gliomas},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16268}
}
EUVIMED